Trial intelligence / Profile preview

Methylphenidate for recovery after traumatic brain injury

ACTRN12615001044516Phase 4Not yet recruiting

Sponsor
Royal Rehab
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in traumatic brain injury (TBI) comparing Ritalin LA with Placebo (2 arms). Primary endpoints: Attention assessed by Paced Auditory Serial Addition Test at Day 96, Attention assessed by Digit Span Test at Day 96 and 1 more. Planned start Jan 2016; status: not yet recruiting.

02

Drugs

methylphenidate
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on ACTRN12615001044516.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615001044516.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call